Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Cozzi-Lepri

Showing results (101-110 of 244) with videos related to

Pageof 25
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|May 26, 2026
Pre-ART platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio and the risk of non-AIDS-events, AIDS-events and mortality in people with HIVPaola Saltini, Alessandro Cozzi-Lepri, Giorgio Bozzi, et al.
Journal of the International AIDS Society|November 14, 2014
CD4 cell count and the risk of infective and non-infective serious non-AIDS events in HIV-positive persons seen for care in ItalyGiordano Madeddu, Antonella D'Arminio Monforte, Enrico Girardi, et al.
The Journal of Antimicrobial Chemotherapy|January 31, 2019
Durability of first-line regimens including integrase strand transfer inhibitors (INSTIs): data from a real-life settingAntonella d'Arminio Monforte, Alessandro Cozzi-Lepri, Antonio Di Biagio, et al.
Journal of the International AIDS Society|January 22, 2019
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohortAnnalisa Mondi, Alessandro Cozzi-Lepri, Alessandro Tavelli, et al.
AIDS (London, England)|February 3, 2021
Time spent with HIV-RNA ≤ 200 copies/ml in a cohort of people with HIV during the U=U eraGiordano Madeddu, Andrea De Vito, Alessandro Cozzi-Lepri, et al.
AIDS (London, England)|April 21, 2011
Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell countGiulia Marchetti, Alessandro Cozzi-Lepri, Esther Merlini, et al.
Plos One|January 12, 2018
HIV-1 co-receptor tropism and liver fibrosis in HIV-infected patientsAnnalisa Saracino, Alessandro Cozzi-Lepri, Milensu Shanyinde, et al.
Travel Medicine and Infectious Disease|February 9, 2024
Impact of COVID-19 pandemic on retention in care of native and migrant people with HIV in the ICONA cohortRoberta Gagliardini, Andrea Giacomelli, Giorgio Bozzi, et al.
Journal of the International AIDS Society|November 15, 2014
Plasma HIV-1 tropism and risk of short-term clinical progression to AIDS or deathMaria Casadellà Fontdevila, Alessandro Cozzi-Lepri, Andrew Phillips, et al.
Journal of the International AIDS Society|November 15, 2014
Determinants of use of the fixed dose combination emtricitabine/rilpivirine/tenofovir (Eviplera) in HIV-infected persons receiving care in ItalyAlessandro Cozzi-Lepri, Sergio Lo Caputo, Franco Maggiolo, et al.
Pageof 25

Showing results (101-110 of 244) with videos related to

Sort By:
Pageof 25
Journal of Acquired Immune Deficiency Syndromes (1999)|May 26, 2026
Pre-ART platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio and the risk of non-AIDS-events, AIDS-events and mortality in people with HIVPaola Saltini, Alessandro Cozzi-Lepri, Giorgio Bozzi, et al.
Journal of the International AIDS Society|November 14, 2014
CD4 cell count and the risk of infective and non-infective serious non-AIDS events in HIV-positive persons seen for care in ItalyGiordano Madeddu, Antonella D'Arminio Monforte, Enrico Girardi, et al.
The Journal of Antimicrobial Chemotherapy|January 31, 2019
Durability of first-line regimens including integrase strand transfer inhibitors (INSTIs): data from a real-life settingAntonella d'Arminio Monforte, Alessandro Cozzi-Lepri, Antonio Di Biagio, et al.
Journal of the International AIDS Society|January 22, 2019
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohortAnnalisa Mondi, Alessandro Cozzi-Lepri, Alessandro Tavelli, et al.
AIDS (London, England)|February 3, 2021
Time spent with HIV-RNA ≤ 200 copies/ml in a cohort of people with HIV during the U=U eraGiordano Madeddu, Andrea De Vito, Alessandro Cozzi-Lepri, et al.
AIDS (London, England)|April 21, 2011
Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell countGiulia Marchetti, Alessandro Cozzi-Lepri, Esther Merlini, et al.
Plos One|January 12, 2018
HIV-1 co-receptor tropism and liver fibrosis in HIV-infected patientsAnnalisa Saracino, Alessandro Cozzi-Lepri, Milensu Shanyinde, et al.
Travel Medicine and Infectious Disease|February 9, 2024
Impact of COVID-19 pandemic on retention in care of native and migrant people with HIV in the ICONA cohortRoberta Gagliardini, Andrea Giacomelli, Giorgio Bozzi, et al.
Journal of the International AIDS Society|November 15, 2014
Plasma HIV-1 tropism and risk of short-term clinical progression to AIDS or deathMaria Casadellà Fontdevila, Alessandro Cozzi-Lepri, Andrew Phillips, et al.
Journal of the International AIDS Society|November 15, 2014
Determinants of use of the fixed dose combination emtricitabine/rilpivirine/tenofovir (Eviplera) in HIV-infected persons receiving care in ItalyAlessandro Cozzi-Lepri, Sergio Lo Caputo, Franco Maggiolo, et al.
Pageof 25